Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,587

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Colorectal Cancer
Interventions
OTHER

placebo

Placebo Comparator

DRUG

Acetylsalicylic acid

Adjuvant Therapy

Trial Locations (67)

2050

Chris O'Brien Lifehouse, Clinical Research Centre, Camperdown

Central Coast Cancer Centre Gosford Hospital, Gosford

2065

Northern Cancer Institute, St Leonards, St Leonards

2305

Newcastle private Hospital, New Lambton Heights

2340

Northwest Cancer Centre Tamworth Hospital, Tamworth

2444

Port Macquarie Base Hospital North Coast Cancer Institute, Port Macquarie

2450

Coffs Harbour Health Campus North Coast Cancer Institute, Coffs Harbour

3165

Monash Health Medical Oncology, Melbourne

3280

St John of God Healthcare Southwest Oncology, Warrnambool

3350

Ballarat Regional Integrated Cancer Centre, Ballarat

3630

Goulburn Valley Health, Shepparton

4814

Townsville Hospital, Douglas

5112

Lyell McEwin Hospital, Elizabeth Vale

7000

Royal Hobart Hospital, Hobart

8140

Christchurch Public Hospital, Christchurch

11420

Dharmais Cancer Hospital, Jakarta

11525

King Fahad Medical City, Riyadh

23561

Shuang Ho Hospital, Taibei

50586

Hospital Kuala Lumpur, Kuala Lumpur

55284

Rumah Sakit RSUP Dr. Sardjito, Yogyakarta

59100

University of Malaysia Medical Center, Kuala Lumpur

110029

All India Institute of Medical Sciences, New Delhi

169610

National Cancer Centre - Singapore, Singapore

400012

Tata Memorial Hospital, Mumbai

560029

Kidwai Memorial Institute of Oncology, Bangalore

632002

Christian Medical College and Hospital, Vellore

695011

Regional Cancer Center, Trivandrum

Unknown

Bankstown-Lidcombe Hospital Bankstown Cancer Centre, Bankstown

Macarthur Cancer Therapy Centre, Campbelltown

Orange Health Service, Orange

St Vincent's Hospital, Sydney

The Tweed Hospital, Tweed Heads

Calvary Mater Newcastle Hospital, Waratah

Royal Darwin Hospital, Tiwi

Royal Brisbane and Women's Hospital, Herston

Toowoomba Hospital, Toowoomba

Border Medical Oncology Research Unit, Albury

Barwon Health Andrew Love Cancer Centre, Geelong

Austin Health Cancer Clinical Trials, Heidelberg

Launceston General Hospital, Launceston

Sir Charles Gairdner Hospital, Nedlands

St John of God Hospital Subiaco, Subiaco

Beijing University Cancer Hospital, Beijing

The First People's Hospital of Foshan City, Foshan

Guangdong General Hospital, Guangzhou

Sixth Affiliated Hospital, Guangzhou

Sun Yat Sen University Cancer Center, Guangzhou

Zhongshan City People's Hospital, Zhongshan

Affiliated Hospital of Nantong University, Nantong

Jinan Central Hospital, Jinan

Yantai Yuhuangding Hospital, Yantai

Koo Foundation Sun Yat Sen Cancer Centre, Taibei

Taipei Medical University Hospital, Taibei

Wan Fang Hospital, Taibei

The Second Affiliated Hospital of Zhejiang University, Hangzhou

Queen Mary Hospital - Hong Kong, Hong Kong

Cipto Mangunkusumo General Hospital, Jakarta

Sarawak General Hospital, Kuching

University Kebangsaan Malaysia Medical Center, Kuala Lumpur

Dunedin Hospital, Dunedin

Johns Hopkins Singapore International Medical Center, Singapore

Tan Tock Seng Hospital, Singapore

Hallym University Sacred Heart Hospital, Anyang-si

Severance Hospital, Seoul

National Cancer Institute, Maharagama

641 037

G. Kuppuswamy Naidu Memorial Hospital, Coimbatore

500 082

Nizam's Institute of Medical Sciences, Hyderabad

All Listed Sponsors
collaborator

Australasian Gastro-Intestinal Trials Group

NETWORK

collaborator

INDOX Cancer Research Network

OTHER

collaborator

University of Sydney

OTHER

lead

National Cancer Centre, Singapore

OTHER